Investors Heavily Search The Goldman Sachs Group, Inc. (GS): Here is What You Need to Know

Core Viewpoint - Goldman Sachs (GS) has experienced a -3.1% return over the past month, underperforming the Zacks S&P 500 composite's +3.1% and the Zacks Financial - Investment Bank industry's -1.3% [1] Earnings Estimates Revisions - For the current quarter, Goldman is expected to report earnings of $8.87 per share, reflecting a +188% change year-over-year, with a slight decrease of -0.1% in the Zacks Consensus Estimate over the last 30 days [3] - The consensus earnings estimate for the current fiscal year is $36.57, indicating a +59.9% change from the previous year, with a -0.6% change in the estimate over the last 30 days [3] - For the next fiscal year, the consensus estimate is $39.79, showing an +8.8% change year-over-year, with a +0.3% change in the estimate over the past month [3] Revenue Growth Potential - The consensus sales estimate for the current quarter is $12.76 billion, indicating a +17.1% year-over-year change [6] - For the current fiscal year, the sales estimate is $51.71 billion, reflecting an +11.8% change, while the next fiscal year's estimate is $53.87 billion, indicating a +4.2% change [6] Last Reported Results and Surprise History - Goldman reported revenues of $14.21 billion in the last quarter, a +16.3% year-over-year change, with an EPS of $11.58 compared to $8.79 a year ago [7] - The reported revenues exceeded the Zacks Consensus Estimate of $12.89 billion by +10.26%, and the EPS surprise was +35.6% [7] - Over the last four quarters, Goldman surpassed consensus EPS estimates three times and topped revenue estimates each time [7] Valuation - Goldman is graded F in the Zacks Value Style Score, indicating it is trading at a premium to its peers [10] - Valuation multiples such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF) are essential for determining whether the stock is fairly valued, overvalued, or undervalued [8][9] Bottom Line - The Zacks Rank 1 suggests that Goldman may outperform the broader market in the near term, despite the premium valuation [11]